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The twenty-sixth NABC conference, held in 2014, New DNA-Editing Approaches: 
Methods, Applications and Policy for Agriculture, included presentations on developments, 
applications, and regulatory concerns for DNA-editing technologies, particularly targeted 
mutagenesis using zinc finger nucleases (ZFNs), transcription activator-like effector 
nucleases (TALENs), and clustered regularly interspaced short palindromic repeats 
(CRISPRs). 
The Student Voice discussions were focused mainly on the following areas: 
• Scientific advocacy,
• Consumer benefits, and
• Regulation.
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1The Student Voice program was inaugurated at NABC 19 in 2007 to promote graduate-student participation 
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Scientific Advocacy
Western civilization has a long history of scientific mistrust and speculation, perhaps most 
famously the conflict which existed between Galileo and the Roman Catholic Church 
 during the Renaissance. Today, there is still a large part of the public which remains 
 skeptical and adverse to Darwin’s theory of evolution. While public distrust of good science 
is always troubling, in the two examples mentioned above, it mainly threatens the scientists’ 
well-being, and does not directly affect the general public that the science of today so often 
tries to help. Major issues that will affect the planet and the human population at large 
in the twenty-first century include feeding nine billion people by 2050 and reducing the 
harmful effects of climate change by reducing greenhouse-gas production. One avenue 
that may help the hunger crisis while reducing inputs to agriculture, thus reducing carbon 
dioxide and other greenhouse-gas emissions, is the use of genetically engineered organisms, 
more commonly known as genetically modified organisms (GMOs).
In the late 1980s it became possible to deliver foreign genes into an organism, and have 
that gene up taken by the organism with expression leading to a more desirable pheno-
type. Many in the plant biology community, especially from the industrial sector, quickly 
noted the merits of such technology and the potential to help farmers and the public. 
Shortly after that, in 1996, Roundup Ready soybean varieties were released to growers, 
who benefitted by simplifying their herbicide-application regimens to only requiring the 
use of glyphosate, the active ingredient in Roundup herbicide. Other traits which were 
released include Bt corn and cotton, which conferred resistance to insect predation. After 
release of these traits and learning about the technology used to generate them, the public 
began to grow restless and wanted to know about the risks related to consuming such foods 
and the effects on livestock that ate the affected seeds. Since then, hundreds of studies 
have been released which indicate that GMO consumption does no harm to livestock 
or humans. However, non-government organizations (NGOs) such as Greenpeace have 
raised the alarm about the “dangers” of genetic modification and the harm that would 
befall the environment. In the true spirit of the precautionary principle and due to public 
pressure, government regulators such as the USDA and FDA quickly issued stringent 
regulations controlling GMO releases, virtually shutting the technology down for use in 
modern agriculture and stifling real life-saving innovations such as Golden Rice.
The resulting outcry from the scientific community, especially the agricultural bio-
technology sector, quickly followed, sparking a public showdown between scientists, 
regulators, the public, and NGOs. Scientists responded quickly with a flurry of studies 
that demonstrated that there are no discernible health effects from consuming GMOs, and 
demonstrating that environmental concerns, while an issue in some circumstances, were 
largely overblown. In spite of this, regulation continues to be excessive and the consumer 
response has been lackluster, and many are still quite wary of GMOs in spite of overwhelm-
ing evidence that they are safe. This combination has left the scientific community quite 
frustrated, and many will not live to see their discoveries reach a hungry public. It is quite 
evident that if we want to see things change, we will need to change tactics, while being 
aware of those who have fought the battle before us, learning from their mistakes, and 
capitalizing on their successes. The timing could not be more critical; we may have the 
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opportunity in the near future to re-cast the narrative, as the public begins to understand 
the applications of the new DNA-editing techniques to plant and animal improvement, 
some of which will soon be up for review and will undoubtedly gain attention.
One of the issues we can examine is that of climate change. Evidence continues to stack 
up supporting the theory of global warming, and that the rise in temperature is tightly 
associated with levels of carbon dioxide and other greenhouse gases in the atmosphere. 
In spite of these facts, it is a politically polarizing subject in the United States, resulting 
in delayed action on climate-change legislation and the regulation of greenhouse-gas 
 production. Rarely, though, does one hear about climate change from climate experts, 
and most information is disseminated through media outlets and politicians, who may 
suffer from greater levels of mistrust even than scientists! As greenhouse-gas emissions 
continue to rise, little is being done due to partisan gridlock while other countries have 
long ago transitioned to green energy solutions such as solar, wind and nuclear sources. 
As we cast alliances with public figures such as celebrities and politicians, we need to be 
wary that we do not alienate half of the country and create a partisan rift.
The pharmaceutical industry has been much more successful at pushing its products 
to the public and they now benefit a vast majority of American consumers, in spite of 
recalls and settlements when some users exhibit extreme side-effects. Though the industry 
is (rightfully) tightly regulated, many new products are released every year, in stark con-
trast to the virtual moratorium placed on GM crops. While few consumers are enthused 
about paying for and taking prescription drugs in the face of side-effects, millions do. 
This begs the question, why do people trust big pharma enough to risk side-effects and 
mistrust ag-biotech advocates the same way they mistrust climate-change advocates? How 
can ag-biotech avoid the polarity that climate change has engendered?
The key difference is advocacy. Pharmaceutical industries have thousands of advocates 
scattered throughout the country. These advocates are physicians and other medical 
practitioners who possess the ability to not only understand how drugs work, but also to 
make sure their patients also understand. While we may never be able to emulate for ag-
biotech exactly what physicians do, we certainly can learn a good deal about the way they 
operate. First, they are actively engaged with the public on a daily basis. Though some of 
them could have been promising researchers, they chose instead to work with the public. 
In the same spirit, some up-and-coming leaders in ag-biotech will have to turn down 
careers in research and pursue avenues where they can engage the public, including legisla-
tion, policy, scientific communication and teaching at the secondary and post-secondary 
level. However, this does not release researchers completely from responsibility, and they 
can play a special role being on the forefront of innovation and having the land-grant 
system in place. Land-grant universities often include extension agents who go out and 
speak to farmers and the public in general about crops. It would not be challenging to set 
aside one day a year for a lab, or at least one of the graduate students, to organize a talk 
about GMOs and explain it from the perspective of someone doing the research. Other 
avenues could include public high-school science demonstrations and botanical gardens. 
Together we could form a network of advocates by sacrificing as little as one day per year 
and become a positive voice for ag-biotech.
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Consumer Benefits
A frustrating issue that was raised in our discussion was the question, “How can we 
appeal directly to consumers?” Clearly, we need to hear more of genetically engineered 
products that directly benefit members of the public at large. Currently, the benefits of 
genetic engineering are clear to growers, but are largely hidden from consumers. A good 
example of a consumer benefit from agricultural biotechnology is the potato—a specialty 
crop—that produces significantly less toxic acrylamide during frying.
Products that lead consumers to realize that the quality of their lives is being improved 
by genetic engineering will open doors to improved communication, which, in turn will 
open doors to acceptance of other products of genetic engineering beneficial not only to 
farmers but also to consumers.
Regulation
A large portion of the NABC 26 meeting focused on regulatory concerns, both within the 
United States and internationally. It is clear that existing regulatory terminology fosters 
confusion about gene-editing approaches, even among leading scientists. During our 
conversation, it was unanimously agreed that a universal, standardized set of definitions 
should be developed and utilized to mitigate confusion about the regulation, adoption, 
and legislation surrounding gene-editing technologies and their resulting products.  
As mentioned by many speakers during the meeting, there is a tendency to regulate the 
process in lieu of the product. This method not only adds many years to the regulatory 
process, but reduces the amount of resources devoted to testing the safety and quality of 
the actual product. Additionally, the extensive regulatory process perpetuates consumer 
distrust of genetic engineering, i.e. “if the product is safe, why does it require so much 
testing and paperwork to release?” Although we recognize there is no easy solution to this 
issue, we propose reduction or elimination of regulation for gene-editing technologies in 
favor of increased regulation and testing of the final organism.
As graduate students, we are especially apprehensive about the impact of regulation on 
funding opportunities for recent graduates. Our greatest concern is the high barrier of entry 
created by the costs and restrictions imposed by existing regulations. The current system 
favors large corporations and narrows research and funding opportunities for entrepreneurs 
and public-sector scientists. This circumstance stifles innovation and limits the ability of 
scientists to address more crucial issues, such as climate change and food security. 
